Showing results (91-100 of 112) with videos related to

Sort By:
Pageof 12
International Journal of Cancer|June 29, 2011
Interleukin (IL)-18, a biomarker of human ovarian carcinoma, is predominantly released as biologically inactive precursorAnna Maria Orengo, Marina Fabbi, Loredana Miglietta, et al.
Oncotarget|June 2, 2016
Targeting folate receptor alpha for cancer treatmentAnthony Cheung, Heather J Bax, Debra H Josephs, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2016
Functional Genomics Uncover the Biology behind the Responsiveness of Head and Neck Squamous Cell Cancer Patients to CetuximabPaolo Bossi, Cristiana Bergamini, Marco Siano, et al.
Disease Markers|December 21, 2017
Are Fusion Transcripts in Relapsed/Metastatic Head and Neck Cancer Patients Predictive of Response to Anti-EGFR Therapies?Paolo Bossi, Marco Siano, Cristiana Bergamini, et al.
Clinical & Experimental Metastasis|November 16, 2014
T-DM1, a novel antibody-drug conjugate, is highly effective against uterine and ovarian carcinosarcomas overexpressing HER2Roberta Nicoletti, Salvatore Lopez, Stefania Bellone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2006
A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancerMichael H Kershaw, Jennifer A Westwood, Linda L Parker, et al.
Journal of Cellular and Molecular Medicine|June 23, 2017
Perfusion of isolated rat kidney with Mesenchymal Stromal Cells/Extracellular Vesicles prevents ischaemic injuryMarilena Gregorini, Valeria Corradetti, Eleonora Francesca Pattonieri, et al.
Oral Oncology|March 9, 2019
A functional gene expression analysis in epithelial sinonasal cancer: Biology and clinical relevance behind three histological subtypesLoris De Cecco, Mara Serena Serafini, Carla Facco, et al.
Cells|April 11, 2020
Ovarian Cancer Translational Activity of the Multicenter Italian Trial in Ovarian Cancer (MITO) Group: Lessons Learned in 10 Years of ExperienceDaniela Califano, Daniela Russo, Giosuè Scognamiglio, et al.
EMBO Molecular Medicine|April 24, 2013
Stathmin regulates mutant p53 stability and transcriptional activity in ovarian cancerMaura Sonego, Monica Schiappacassi, Sara Lovisa, et al.
Pageof 12